XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.20.1

BIOLOGICAL ASSETS | 12 Months Ended
--- | ---
Dec. 31, 2019
BIOLOGICAL ASSETS |
BIOLOGICAL ASSETS | 13.BIOLOGICAL ASSETS The rollforward of biological assets is set forth below:
Balances on December 31, 2017 |  | 4,548,897
Addition |  | 1,285,490
Depletion |  | (709,547)
Loss on fair value adjustment |  | (129,187)
Disposal |  | (47,124)
Other write-offs |  | (12,624)
Balances on December 31, 2018 |  | 4,935,905
Business combination with Fibria (1) |  | 4,579,526
Addition |  | 2,849,039
Depletion |  | (1,905,118)
Gain on fair value adjustment |  | 185,399
Disposal |  | (23,764)
Other write-offs |  | (49,488)
Balances on December 31, 2019 |  | 10,571,499
| 1) |  | Business combination with Fibria and its subsidiaries held on January 3, 2019, Note 1.2.1.
The calculation of fair value of the biological assets falls under Level 3 in the hierarchy set forth in IFRS 13 — Measurement of Fair Value, due to the complexity and structure of calculation. The main assumptions, IMA, discount rate, and selling price stand out as being the most sensitive where increases or reductions in these assumptions generate significant gains or losses in the measurement of fair value. The Company’s biological assets are mainly of eucalyptus forest for reforestation used to supply wood to pulp and paper manufactory facility and are located in the states of São Paulo, Bahia, Espírito Santo, Maranhão, Minas Gerais, Pará, Piauí and Tocantins. Permanent preservation and legal reserve areas were not included in the biological assets fair value measurements due to its nature. The fair value of eucalyptus forests is determined semiannually through the income approach method by using the discounted cash flow method. The assumptions used in measurement of the fair value of biological assets were: i)Average cycle of forest formation of 6 and 7 years; ii)Effective area of forest from the 3 rd year of planting; iii)Average annual increment consists of the estimated volume of production of wood with bark in m 3 per hectare, ascertained based on the genetic material used in each region, silvicultural practices and forest management, production potential, climate factors and ground conditions; iv)The estimated average standard cost per hectare includes expenses on silvicultural and forest management applied to each year of formation of the biological cycle of forests, plus costs of land lease agreements and opportunity cost of own land; v)The average gross selling prices of eucalyptus were based on specialized research on transactions carried out by the Company with independent third parties and/or weighted by the cost of formation plus cost of capital plus estimated margin for regions where there is no market benchmark available; and vi)The discount rate used in cash flows is measured based on capital structure and other economic assumptions in an independent market participant in the sale of standing wood (forests). The following table discloses the measurement of the premises adopted:
|  | December 31,
|  | 2019
Planted useful area (hectare) |  | 988,720
Mature assets |  | 86,352
Immature assets |  | 902,368
Average annual growth (IMA) - m3 /hectare /year |  | 38.34
Average gross sale price of eucalyptus - R$/m3 |  | 66.81
Discount rate - % |  | 8.4%
The pricing model considers net cash flows, after deduction of taxes on profit at the applicable rates. The fair value adjustment recognized in year ended December 31, 2019 is justified by variation of indicators mentioned above, which combined resulted in a positive variation of R$185,399. The fair value adjustment was recognized under other operating income (expense), net.
|  | December 31,
|  | 2019
Physical changes |  | (347,409)
Price |  | 532,808
|  | 185,399
The Company manages the financial risks related to agricultural activities in a preventive manner. To reducing risks from edaphoclimatic factors, the weather is monitored through meteorological stations and, in the event of pests and diseases, our Department of Forestry Research and Development, an area specialized in physiological and phytosanitary aspects, has procedures to diagnose and act rapidly against any occurrences and losses. The Company has no biological assets pledged in the year ended December 31, 2019.

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of detailed information about biological assets. [Refer: Biological assets] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 41 -IssueDate 2019-01-01 -Paragraph 43 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2019-en-r&anchor=para_43&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfDetailedInformationAboutBiologicalAssetsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration